Cellectis
CLLS
#7791
Rank
C$0.47 B
Marketcap
C$4.76
Share price
1.19%
Change (1 day)
178.28%
Change (1 year)

Market capitalization of Cellectis (CLLS)

Market cap: C$0.47 Billion

As of April 2026 Cellectis has a market cap of C$0.47 Billion. This makes Cellectis the world's 7791th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Cellectis from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026C$0.47 B-26.7%
2025C$0.65 B216.17%
2024C$0.20 B-29.42%
2023C$0.29 B120.21%
2022C$0.13 B-72.8%
2021C$0.48 B-69.97%
2020C$1.62 B66.89%
2019C$0.97 B-2.29%
2018C$0.99 B-21.32%
2017C$1.26 B55.74%
2016C$0.81 B-45.38%
2015C$1.48 B193.11%
2014C$0.50 B613.01%
2013C$71.27 M

End of Day market cap according to different sources

On Apr 3rd, 2026 the market cap of Cellectis was reported to be:

C$0.34 Billion
by Nasdaq info icon info icon
C$0.47 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Regeneron Pharmaceuticals
REGN
C$112.32 B 23,380.77%๐Ÿ‡บ๐Ÿ‡ธ USA
uniQure
QURE
C$1.49 B 212.82%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
Novavax
NVAX
C$1.74 B 265.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
C$0.64 B 33.79%๐Ÿ‡บ๐Ÿ‡ธ USA